Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Neoplasms 2Inflammation 2Uveal Melanoma 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Eye Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cachexia 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Exercise 19Drug Therapy 18pembrolizumab 13Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Paclitaxel 9Dexamethasone 9Nivolumab 8Standard of Care 7Oxaliplatin 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Control Groups 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Ibuprofen × Clear all
NCT04907864 2021-06-01

MIRACLE

Kyunghee University Medical Center

Phase 2 Unknown
112 enrolled
GastrointestinalThoracic

Biliary Tract Neoplasms, Cachexia, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT01786200 2013-02-07

Physiological Effects of Altering Cancer-related Inflammation

NHS Greater Glasgow and Clyde

Phase NA Unknown
60 enrolled
Gastrointestinal

Colonic Neoplasms, Inflammation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡